Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated August 07, 2026 3 min read

Apollo Hospitals faces a pivotal Q1 FY27 as it balances a seasonally softer quarter for elective procedures against strong structural demand for complex specialties like oncology and cardiac care. Investors will be closely watching for the promised breakeven of the Apollo 24/7 digital business and the ramp-up status of its new hospital capacity.

Quick Details

Results date	August 12, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 6,605.5 Cr
Previous quarter PAT	Rs. 529.2 Cr
Previous quarter EBITDA margin	15.3%
Net debt (latest quarter)	Rs. 865.9 Cr
Market cap	Rs. 131,493.56 Cr
CMP	Rs. 8980.5

Apollo Hospitals Enterprise Limited Q1 Results Date and Time

The board meeting is scheduled for August 12, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026.

What to expect from Apollo Hospitals Enterprise Limited's Q1 FY27 results

Apollo Hospitals enters Q1 FY27 with a strong structural tailwind, as management targets 12-14% organic revenue growth for established hospitals following a 13-14% growth rate in Q4 FY26. The company is navigating a seasonal elective lull, but management has highlighted robust demand for complex procedures and a 28% month-on-month rise in dengue cases by May 2026 as potential offsets to hospital occupancy. A critical focus for the quarter is the digital business, where management has guided toward ex-ESOP breakeven for Apollo 24/7 in Q1 FY27, following a cash loss of Rs. 16.4 Cr in Q4 FY26. Furthermore, the company is managing a new hospital expansion pipeline, with 185 beds already operational out of 1,400 planned, and is tracking against a Rs. 150 Cr EBITDA loss guidance for these units in FY27. Finally, the upcoming earnings call will likely address the sustainability of the 25.5% EBITDA margin in established hospitals and the progress of the Apollo Healthtech demerger, which is expected to conclude by Q4 FY27.

Key Things To Watch

Performance vs Guidance Tracking: Tracking key management targets for FY27.

Apollo 24/7 ex-ESOP breakeven — Q1 FY27 target — pivotal test this quarter
Healthcare Services established EBITDA margin — 25.5% sustainable — tracking progress
New hospital EBITDA loss — Rs. 150 Cr for FY27 — tracking quarterly run-rate

Digital and Pharmacy Trajectory: Monitoring the path toward HealthCo profitability.

Digital cash loss trend vs Rs. 16.4 Cr in Q4 FY26
Offline pharmacy margin sustainability vs 7.7% in Q4 FY26
HealthCo annualized revenue run-rate progress toward Rs. 25,000 Cr target

Hospital Operational Focus: Updates on capacity and patient metrics.

Occupancy levels in Q1 vs 68% in Q4 FY26
New bed commissioning status for Bangalore Sarjapur and Gurugram units
ALOS and ARPOB trends in the context of robotic surgery adoption

Strategic and Financial Updates: Key corporate actions and balance sheet health.

Demerger and listing timeline for Apollo Healthtech
Completion status of AHLL divestment to Cloudnine

Frequently Asked Questions

Is Apollo Hospitals' revenue growing?

Consolidated revenue grew 16% YoY to Rs. 25,229 Cr in FY26, with Q4 FY26 revenue reaching Rs. 6,605 Cr. Management expects organic growth for established hospitals to continue in the 12-14% range for FY27.

When does Apollo expect its digital business to break even?

Management has guided for Apollo 24/7 to reach EBITDA breakeven (excluding ESOP) in Q1 FY27. The digital cash loss narrowed to Rs. 16.4 Cr in Q4 FY26, marking progress toward this goal.

What is the status of the new hospital expansion?

As of Q4 FY26, 185 beds were operational out of a 1,400-bed pipeline. The company targets having 500-600 beds operational by mid-FY27, with new units expected to reach breakeven by FY28.